The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients - PubMed (original) (raw)
. 2015 Jan 15;60(2):208-15.
doi: 10.1093/cid/ciu787. Epub 2014 Oct 9.
Elizabeth M Hechenbleikner 2, Andrew C Goodwin 1, Ruchi Badani 3, Ellen M Stein 1, Mark G Lazarev 1, Brandon Ellis 4, Karen C Carroll 4, Emilia Albesiano 1, Elizabeth C Wick 2, Elizabeth A Platz 5, Drew M Pardoll 6, Cynthia L Sears 6
Affiliations
- PMID: 25305284
- PMCID: PMC4351371
- DOI: 10.1093/cid/ciu787
The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients
Annemarie Boleij et al. Clin Infect Dis. 2015.
Abstract
Background: Enterotoxigenic Bacteroides fragilis (ETBF) produces the Bacteroides fragilis toxin, which has been associated with acute diarrheal disease, inflammatory bowel disease, and colorectal cancer (CRC). ETBF induces colon carcinogenesis in experimental models. Previous human studies have demonstrated frequent asymptomatic fecal colonization with ETBF, but no study has investigated mucosal colonization that is expected to impact colon carcinogenesis.
Methods: We compared the presence of the bft gene in mucosal samples from colorectal neoplasia patients (cases, n = 49) to a control group undergoing outpatient colonoscopy for CRC screening or diagnostic workup (controls, n = 49). Single bacterial colonies isolated anaerobically from mucosal colon tissue were tested for the bft gene with touch-down polymerase chain reaction.
Results: The mucosa of cases was significantly more often bft-positive on left (85.7%) and right (91.7%) tumor and/or paired normal tissues compared with left and right control biopsies (53.1%; P = .033 and 55.5%; P = .04, respectively). Detection of bft was concordant in most paired mucosal samples from individual cases or controls (75% cases; 67% controls). There was a trend toward increased bft positivity in mucosa from late- vs early-stage CRC patients (100% vs 72.7%, respectively; P = .093). In contrast to ETBF diarrheal disease where bft-1 detection dominates, bft-2 was the most frequent toxin isotype identified in both cases and controls, whereas multiple bft isotypes were detected more frequently in cases (P ≤ .02).
Conclusions: The bft gene is associated with colorectal neoplasia, especially in late-stage CRC. Our results suggest that mucosal bft exposure is common and may be a risk factor for developing CRC.
Keywords: Bacteroides fragilis toxin; colorectal cancer; enterotoxigenic Bacteroides fragilis; mucosal microbiota.
© The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
Figures
Figure 1.
Case and control bft status. A, Overall, cases (n = 26; no antibiotics) were more often _bft-_positive than controls (n = 49; P = .054). bft positivity was present significantly more often in both left- and right-sided colorectal neoplasia cases compared with left and right colon biopsies from controls (Fisher exact test, P = .033 and P = .040, respectively). B, Patients with colorectal cancer (CRC) (n = 23; no antibiotics) were stratified by tumor stage (early, stage I/II; and late, stage III/IV). All 12 late-stage CRC patients (100%) were _bft-_positive compared with 67.3% of all controls and 71.1% of controls without adenomas (Fisher exact test, P = .026 and P = .046, respectively). Cases with adenomas were excluded from this analysis.
Similar articles
- Enterotoxigenic Bacteroides fragilis: A Possible Etiological Candidate for Bacterially-Induced Colorectal Precancerous and Cancerous Lesions.
Zamani S, Taslimi R, Sarabi A, Jasemi S, Sechi LA, Feizabadi MM. Zamani S, et al. Front Cell Infect Microbiol. 2020 Jan 17;9:449. doi: 10.3389/fcimb.2019.00449. eCollection 2019. Front Cell Infect Microbiol. 2020. PMID: 32010637 Free PMC article. - The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
Haghi F, Goli E, Mirzaei B, Zeighami H. Haghi F, et al. BMC Cancer. 2019 Sep 5;19(1):879. doi: 10.1186/s12885-019-6115-1. BMC Cancer. 2019. PMID: 31488085 Free PMC article. - Screening for enterotoxigenic Bacteroides fragilis in stool samples.
Keenan JI, Aitchison A, Purcell RV, Greenlees R, Pearson JF, Frizelle FA. Keenan JI, et al. Anaerobe. 2016 Aug;40:50-3. doi: 10.1016/j.anaerobe.2016.05.004. Epub 2016 May 7. Anaerobe. 2016. PMID: 27166180 - Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis.
Sears CL, Geis AL, Housseau F. Sears CL, et al. J Clin Invest. 2014 Oct;124(10):4166-72. doi: 10.1172/JCI72334. Epub 2014 Aug 8. J Clin Invest. 2014. PMID: 25105360 Free PMC article. Review. - Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes.
Sears CL. Sears CL. Clin Microbiol Rev. 2009 Apr;22(2):349-69, Table of Contents. doi: 10.1128/CMR.00053-08. Clin Microbiol Rev. 2009. PMID: 19366918 Free PMC article. Review.
Cited by
- The intestinal microbiome and health.
Tuddenham S, Sears CL. Tuddenham S, et al. Curr Opin Infect Dis. 2015 Oct;28(5):464-70. doi: 10.1097/QCO.0000000000000196. Curr Opin Infect Dis. 2015. PMID: 26237547 Free PMC article. Review. - Microbial and molecular differences according to the location of head and neck cancers.
Kim YK, Kwon EJ, Yu Y, Kim J, Woo SY, Choi HS, Kwon M, Jung K, Kim HS, Park HR, Lee D, Kim YH. Kim YK, et al. Cancer Cell Int. 2022 Mar 26;22(1):135. doi: 10.1186/s12935-022-02554-6. Cancer Cell Int. 2022. PMID: 35346218 Free PMC article. - Grow With the Challenge - Microbial Effects on Epithelial Proliferation, Carcinogenesis, and Cancer Therapy.
von Frieling J, Fink C, Hamm J, Klischies K, Forster M, Bosch TCG, Roeder T, Rosenstiel P, Sommer F. von Frieling J, et al. Front Microbiol. 2018 Sep 20;9:2020. doi: 10.3389/fmicb.2018.02020. eCollection 2018. Front Microbiol. 2018. PMID: 30294304 Free PMC article. Review. - Characterization of Mucosal Dysbiosis of Early Colonic Neoplasia.
Hong BY, Ideta T, Lemos BS, Igarashi Y, Tan Y, DiSiena M, Mo A, Birk JW, Forouhar F, Devers TJ, Weinstock GM, Rosenberg DW. Hong BY, et al. NPJ Precis Oncol. 2019 Nov 14;3:29. doi: 10.1038/s41698-019-0101-6. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 31754633 Free PMC article. - Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases.
Quaranta G, Sanguinetti M, Masucci L. Quaranta G, et al. Front Immunol. 2019 Nov 26;10:2653. doi: 10.3389/fimmu.2019.02653. eCollection 2019. Front Immunol. 2019. PMID: 31827467 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
- P50 CA062924/CA/NCI NIH HHS/United States
- R01 CA151393/CA/NCI NIH HHS/United States
- T32 CA126607/CA/NCI NIH HHS/United States
- P30 CA021765/CA/NCI NIH HHS/United States
- 5T32 CA126607-05/CA/NCI NIH HHS/United States
- K08 DK087856/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical